Seroprevalence of SARS-CoV-2 Antibodies in Symptomatic Individuals Is Higher than in Persons Who Are at Increased Risk Exposure: The Results of the Single-Center, Prospective, Cross-Sectional Study

Seroprevalence of SARS-CoV-2 Antibodies in Symptomatic Individuals Is Higher than in Persons Who Are at Increased Risk Exposure: The Results of the Single-Center, Prospective, Cross-Sectional Study

The present study aimed to assess antibody seropositivity prevalence among symptomatic individuals and individuals with a high risk of occupational exposure to SARS-CoV-2. Participants from Chelyabinsk (Russian Federation) who were at an increased risk of exposure to SARS-CoV-2 (high-risk group, <...

Full description

Bibliographic Details
Main Authors: Alexandr Zurochka, Maria Dobrinina, Vladimir Zurochka, Desheng Hu, Alexandr Solovyev, Liana Ryabova, Igor Kritsky, Roman Ibragimov, Alexey Sarapultsev
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Vaccines
Subjects:
antibody
COVID-19
focus groups
global health
high-risk groups
seroprevalence
Online Access:https://www.mdpi.com/2076-393X/9/6/627

Internet

https://www.mdpi.com/2076-393X/9/6/627

Similar Items